AELIS — Aelis Farma SA Income Statement
0.000.00%
Last trade - 00:00
- €172.70m
- €149.89m
- €3.81m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 9.07 | 3.81 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.63 | 2.99 | 2.84 | 6.52 | 12.3 |
Operating Profit | -2.63 | -2.99 | -2.84 | 2.55 | -8.53 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.7 | -3.17 | -3.04 | 1.76 | -14.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.7 | -3.17 | -2.09 | 0.574 | -14.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.7 | -3.17 | -2.09 | 0.574 | -14.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.7 | -3.17 | -2.09 | 0.574 | -14.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.217 | -0.254 | -0.167 | 0.046 | -1.14 |
Dividends per Share |